Evaxion Biotech A/S reported selling 2,000 American Depositary Shares (ADSs) between August 12 and September 5, 2024, raising approximately $4,877 at an average price of $2.81 per ADS, with associated amendments to their Articles of Association. This filing includes capital increases to nominal DKK 55,780,546 due to the issuance of these ADSs and new warrants granted to consultants.